Brachial Plexus Injury Market Report 2026

The brachial plexus injury market size has grown rapidly in recent years. It will grow from $6.45 billion in 2025 to $7.25 billion in 2026 at a compound annual growth rate (CAGR) of 12.5%. The growth in the historic period can be attributed to improvements in trauma care services, expansion of surgical expertise in nerve repair, availability of diagnostic imaging technologies, increased incidence of traumatic injuries, development of rehabilitation protocols.

The brachial plexus injury market size is expected to see rapid growth in the next few years. It will grow to $11.56 billion in 2030 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to increasing investments in nerve regeneration research, rising adoption of robotic-assisted surgery, expansion of personalized rehabilitation programs, growing focus on minimally invasive procedures, increasing awareness of early diagnosis benefits. Major trends in the forecast period include increasing adoption of advanced imaging diagnostics, rising demand for microsurgical interventions, growing use of rehabilitation technologies, expansion of multidisciplinary treatment approaches, enhanced focus on early intervention strategies.

An increase in road accidents is expected to drive the growth of the brachial plexus injury market in the coming years. Higher vehicle usage and insufficient enforcement of traffic regulations heighten risks associated with speeding and driver negligence, resulting in more road accident cases. Treatment for brachial plexus injuries caused by road accidents usually involves a combination of surgical procedures, such as nerve grafting or nerve transfer, along with rehabilitative therapies aimed at restoring function and mobility in the affected limb. For example, in January 2024, a report by The Road Safety Authority, an Ireland-based government agency, indicated that preliminary traffic collision data showed a 19% increase in road deaths in 2023 compared to 2022. Consequently, the rise in road accidents is contributing to the growth of the brachial plexus injury market.

Key companies in the brachial plexus injury market are pursuing strategic partnerships to enhance their product offerings, expand global reach, and utilize advanced technologies for improved user experience and monetization. A strategic partnership generally involves collaboration between two or more organizations to combine resources, expertise, and efforts to achieve shared goals. For instance, in June 2025, 3D Systems Corporation, a U.S.-based additive manufacturing and 3D printing solutions company, partnered with TISSIUM, a France-based medtech firm specializing in biomorphic polymers for tissue reconstruction, to receive FDA approval for COAPTIUM CONNECT with TISSIUM Light, a first-of-its-kind, fully bioabsorbable, sutureless peripheral nerve repair device. The approval highlights the clinical effectiveness of TISSIUM’s proprietary biomorphic polymers and represents a significant milestone in applying 3D Systems’ high-resolution bioprinting technology in medical applications.

In January 2024, Catholic Medical Center (CMC), a US-based nonprofit acute-care hospital and regional health system, merged with HCA Healthcare Inc. for an undisclosed amount. The merger is intended to ensure the continuity and enhancement of CMC's mission of health and healing, supporting its objectives while investing in its staff and facilities, thereby strengthening healthcare delivery in the region over the long term. HCA Healthcare Inc. is a US-based healthcare services company that provides treatment for brachial plexus injuries.

Major companies operating in the brachial plexus injury market are Medtronic plc, Johnson And Johnson, Stryker Corporation, Integra LifeSciences Holdings Corporation, Zimmer Biomet Holdings Inc., Smith And Nephew plc, Arthrex Inc., B. Braun Melsungen AG, Karl Storz SE And Co. KG, CONMED Corporation, MicroPort Scientific Corporation, Wright Medical Group N.V., LivaNova PLC, Olympus Corporation, Fujifilm Holdings Corporation, Baxter International Inc., Boston Scientific Corporation, Terumo Corporation, DJO Global Inc., Aesculap Inc., AxoGen Inc., NuVasive Inc.

North America was the largest region in the brachial plexus injury market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brachial plexus injury market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the brachial plexus injury market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the brachial plexus injury market by increasing costs of imported surgical instruments, imaging systems, electrodiagnostic devices, and rehabilitation equipment. Hospitals and specialty clinics in North America and Europe are most affected due to reliance on advanced imported medical technologies, while Asia-Pacific faces cost pressures in device procurement. These tariffs are increasing treatment expenses and delaying technology upgrades. However, they are also supporting domestic medical device manufacturing, regional supplier development, and localized innovation in nerve repair solutions.

The brachial plexus injury market research report is one of a series of new reports that provides brachial plexus injury market statistics, including brachial plexus injury industry global market size, regional shares, competitors with a brachial plexus injury market share, detailed brachial plexus injury market segments, market trends and opportunities, and any further data you may need to thrive in the brachial plexus injury industry. This brachial plexus injury market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A brachial plexus injury occurs when the network of nerves responsible for movement and sensation in the shoulder, arm, and hand is damaged or traumatized. This type of injury often results from accidents, complications during childbirth, or sports-related incidents, causing a range of impairments from mild weakness to complete paralysis. Management typically involves a combination of treatments based on the severity of the injury.

The primary types of brachial plexus injuries include avulsion, rupture, neurapraxia, axonotmesis, neurotmesis, and neuroma. Avulsion occurs when the nerve is entirely torn from its attachment to the spinal cord and usually requires complex surgical procedures to restore function. Diagnosis methods include clinical examination, electrodiagnostic tests, and imaging studies, while treatment options such as therapy and surgery are applied for causes including trauma, inflammation, contact sports, tumors, radiation therapy, and other factors.

The brachial plexus injury market consists of revenues earned by entities providing services such as surgical interventions, rehabilitation therapies, diagnostic imaging, and long-term care management for individuals affected by brachial plexus injuries. The market value includes the value of related goods sold by the service provider or included within the service offering. The brachial plexus injury market also includes sales of surgical implants, orthotic devices, pain management medications, and diagnostic equipment used for assessing nerve function and injury severity. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.